Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01096329 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®
A Phase 1 study, sponsored by VIVUS.
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT01096329 is a Phase 1 study that was terminated before completion, run by VIVUS. The registered enrollment target is 16 participants.
The verdict
NCT01096329, a Phase 1 study, was terminated before completion, sponsored by VIVUS.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the absorption of the testosterone spray is the same as the Intrinsa® Patch.
Interventions
- DRUG Testosterone Spray 5% and 1%
- DRUG Intrinsa® Patch and Testosterone Spray 5%
- DRUG Intrinsa® Patch and Testosterone Spray 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01096329
The ClinicalTrials.gov registry entry for NCT01096329 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VIVUS, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Testosterone Spray 5% and 1% is the first listed.
NCT01096329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01096329 about?
NCT01096329 is a clinical study titled "A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®". The purpose of this study is to determine if the absorption of the testosterone spray is the same as the Intrinsa® Patch.
What is the current status of trial NCT01096329?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2010-02.
What interventions are being tested in trial NCT01096329?
The interventions under investigation include: Testosterone Spray 5% and 1% (DRUG), Intrinsa® Patch and Testosterone Spray 5% (DRUG), Intrinsa® Patch and Testosterone Spray 1% (DRUG).
Who is sponsoring clinical trial NCT01096329?
This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.